Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,026
archived clinical trials in
Epilepsy

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Idaho
mi
from
Boise, ID
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Idaho
mi
from
Boise, ID
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Illinois
mi
from
Chicago, IL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Illinois
mi
from
Chicago, IL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Kansas
mi
from
Manhattan, KA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Kansas
mi
from
Manhattan, KA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Kentucky
mi
from
Lexington, KY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Maryland
mi
from
Baltimore, MD
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Maryland
mi
from
Baltimore, MD
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Michigan
mi
from
Detroit, MI
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Nevada
mi
from
Reno, NV
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Nevada
mi
from
Reno, NV
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New Hampshire
mi
from
Lebanon, NH
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New Hampshire
mi
from
Lebanon, NH
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New Jersey
mi
from
Hackensack, NJ
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New Jersey
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New York
mi
from
Bronx, NY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New York
mi
from
Bronx, NY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New York
mi
from
New York, NY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New York
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New York
mi
from
Stony Brook, NY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New York
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, North Carolina
mi
from
Durham, NC
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, North Carolina
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Ohio
mi
from
Columbus, OH
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Ohio
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Oklahoma
mi
from
Oklahoma City, OK
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Oregon
mi
from
Portland, OR
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Oregon
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Pennsylvania
mi
from
Philadelphia, PA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Tennessee
mi
from
Nashville, TN
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Tennessee
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
Dallas, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
Dallas, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
Fort Worth, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
San Antonio, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
San Antonio, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Virginia
mi
from
Norfolk, VA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Virginia
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Wisconsin
mi
from
Madison, WI
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, California
mi
from
Orange, CA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, California
mi
from
Orange, CA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, North Carolina
mi
from
Winston-Salem, NC
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, North Carolina
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Tennessee
mi
from
Memphis, TN
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Tennessee
mi
from
Memphis, TN
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
mi
from
Greenville, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
mi
from
Greenville, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
Australia, New South Wales
mi
from
Randwick,
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
Australia, New South Wales
mi
from
Randwick,
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Arizona
mi
from
Tucson, AZ
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Florida
mi
from
Loxahatchee Groves, FL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Florida
mi
from
Loxahatchee Groves, FL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Minnesota
mi
from
Saint Paul, MN
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Minnesota
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Missouri
mi
from
Saint Louis, MO
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Missouri
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
Medical University of South Carolina
mi
from
Charleston, SC
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
Yale University School of Medicine
mi
from
New Haven, CT
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
Mount Sinai-West
mi
from
New York, NY
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
Mount Sinai-West
mi
from
New York, NY
Click here to add this to my saved trials
In Vivo Imaging of Therapeutic Electric Current Flow
In Vivo Imaging of Therapeutic Electric Current Flow
Status: Enrolling
Updated:  4/4/2018
University of Florida
mi
from
Gainesville, FL
In Vivo Imaging of Therapeutic Electric Current Flow
In Vivo Imaging of Therapeutic Electric Current Flow
Status: Enrolling
Updated: 4/4/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated:  4/17/2018
Montefiore Medical Center
mi
from
Bronx, NY
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated: 4/17/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated:  4/17/2018
University of Cincinnati
mi
from
Cincinnati, OH
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated: 4/17/2018
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated:  4/17/2018
University of California at San Francisco
mi
from
San Francisco, CA
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated: 4/17/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Austin Epilepsy Care Center
mi
from
Austin, TX
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Austin Epilepsy Care Center
mi
from
Austin, TX
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Bradenton Research Center
mi
from
Bradenton, FL
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Bradenton Research Center
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Clinical Trials, Inc.
mi
from
Little Rock, AR
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Clinical Trials, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Consultants in Epilepsy and Neurology, PLLC
mi
from
Boise, ID
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Consultants in Epilepsy and Neurology, PLLC
mi
from
Boise, ID
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Johns Hopkins University
mi
from
Baltimore, MD
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials